Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01319253 · ClinicalTrials.gov registry record
A Comparator Study Evaluating Microbiological Resistance and Effects of Alternating Inhaled Antibiotic Therapies
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 27
- Enrollment target
NCT01319253 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 27 participants.
The verdict
NCT01319253 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
This is a pilot study of inhaled antibiotic regimens is a pilot study examining clinical and laboratory endpoints of patients on inhaled antibiotic treatments. We hypothesize that alternation therapy utilizing Cayston and Tobi will inhibit antibiotic resistance and that alternation therapy will result in a decreased incidence of antibiotic resistance to Cystic Fibrosis (CF) microbial isolates. The long term strategic goal is to develop a model biometric system for selecting a patient's optimal inhaled antibiotic regimen by utilizing clinical and microbiological parameters.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2011-03 |
| Est. Completion | 2015-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01319253
The ClinicalTrials.gov registry entry for NCT01319253 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01319253 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01319253 about?
NCT01319253 is a clinical study titled "A Comparator Study Evaluating Microbiological Resistance and Effects of Alternating Inhaled Antibiotic Therapies". This is a pilot study of inhaled antibiotic regimens is a pilot study examining clinical and laboratory endpoints of patients on inhaled antibiotic treatments. We hypothesize that alternation therapy utilizing Cayston and Tobi will inhibit antibiotic resistance and that alternation therapy will resu...
What is the current status of trial NCT01319253?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2011-03. Estimated completion is 2015-10.
Who is sponsoring clinical trial NCT01319253?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.